BML is Lunching Apalunix 60 mg tablet which is an androgen receptor inhibitor indicated for the treatment of patients with
- Metastatic castration-sensitive prostate cancer
- Non-metastatic castration resistant prostate cancer.
Apalunix works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of cancer cells.
|Available Pack Size